| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJI.201847855 |
| P698 | PubMed publication ID | 30664244 |
| P50 | author | Alf Grandien | Q91139903 |
| Jessica M Lindvall | Q42417427 | ||
| P2093 | author name string | Kari Högstrand | |
| Anne Sundblad | |||
| P2860 | cites work | Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation | Q80139485 |
| A network of genetic events sufficient to convert normal human cells to a tumorigenic state | Q81434910 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| BMI1: A Biomarker of Hematologic Malignancies | Q26750676 | ||
| Gene Expression Omnibus: NCBI gene expression and hybridization array data repository | Q27860523 | ||
| Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma | Q28250998 | ||
| A mass spectrometric-derived cell surface protein atlas | Q28546580 | ||
| PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes | Q29547229 | ||
| Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. | Q30985619 | ||
| Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia | Q34185658 | ||
| The regulation of INK4/ARF in cancer and aging | Q34575801 | ||
| Molecular signatures database (MSigDB) 3.0. | Q35019708 | ||
| Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice | Q35608164 | ||
| Bmi-1: At the crossroads of physiological and pathological biology | Q36121000 | ||
| Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma. | Q36204839 | ||
| Molecular pathogenesis of multiple myeloma and its premalignant precursor | Q36290238 | ||
| Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma | Q36741637 | ||
| IRF4 addiction in multiple myeloma | Q36891060 | ||
| Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting. | Q37162837 | ||
| Heterogeneity of genomic evolution and mutational profiles in multiple myeloma | Q37528285 | ||
| Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification | Q38134685 | ||
| Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma. | Q40633414 | ||
| Comprehensive genomic profiling of IgM multiple myeloma identifies IRF4 as a prognostic marker. | Q40858735 | ||
| Guidelines for the use of flow cytometry and cell sorting in immunological studies | Q41918189 | ||
| Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy | Q43024864 | ||
| ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays | Q43536416 | ||
| Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies | Q44664483 | ||
| Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells. | Q50927930 | ||
| Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. | Q51959485 | ||
| Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. | Q51981842 | ||
| Differential expression of apoptosis, Bcl-x and c-Myc in normal and malignant lymphoid tissues. | Q52999419 | ||
| Transformation of mouse T cells requires MYC and AKT activity in conjunction with inhibition of intrinsic apoptosis. | Q54966913 | ||
| Mouse models of multiple myeloma: technologic platforms and perspectives. | Q55038802 | ||
| Multiple myeloma | Q56657250 | ||
| MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity | Q57036262 | ||
| The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice | Q57338722 | ||
| Negative selection of multireactive B cell clones in normal adult mice | Q72524379 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 454-461 | |
| P577 | publication date | 2019-02-04 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Transformation of mature mouse B cells into malignant plasma cells in vitro via introduction of defined genetic elements | |
| P478 | volume | 49 |
Search more.